International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is characterized by proliferation of malignant plasma cells in the bone marrow. MM evolves from the clonal premalignant disorder monoclonal gammopathy of unknown significance (MGUS) by sequential genetic changes involving many different genes, resulting in dysregulated growth of multiple clones of plasma cells. The migration, survival, and proliferation of these clones require the direct and indirect interactions with the non-hematopoietic cells of the bone marrow. We develop a hybrid discrete-continuous model of MM development from the MGUS stage. The discrete aspect of the model is observed at the cellular level: cells are represented as individ...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Although multiple myeloma (MM) is characterized by a monoclonal expansion of plasma cells, it has be...
Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone mar...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Multiple myeloma is a malignant bone marrow plasma cell tumor which is responsible for approximately...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
Multiple Myeloma (MM) is a haematological malignancy characterised by the clonal expansion of plasma...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone ...
[Purpose]: Since the pioneering work of Salmon and Durie, quantitative measures of tumor burden in m...
Heterogeneity of stem cell clones provide a key ingredient in altered hematopoiesis and is of main i...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
It is clear that cancers comprise a mixture of clones, a feature termed intra-clonal heterogeneity, ...
Multiple myeloma (MM) is a hematological malignancy resulting from the uncontrolled proliferation of...
Clonal heterogeneity and clonal evolution have emerged as critical concepts in the field of oncology...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Although multiple myeloma (MM) is characterized by a monoclonal expansion of plasma cells, it has be...
Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone mar...
International audienceMultiple myeloma (MM) is a genetically complex hematological cancer that is ch...
Multiple myeloma is a malignant bone marrow plasma cell tumor which is responsible for approximately...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
Multiple Myeloma (MM) is a haematological malignancy characterised by the clonal expansion of plasma...
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone ...
[Purpose]: Since the pioneering work of Salmon and Durie, quantitative measures of tumor burden in m...
Heterogeneity of stem cell clones provide a key ingredient in altered hematopoiesis and is of main i...
The standard model of multiple myeloma (MM) oncogenesis is based on the genetic instability of MM ce...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
It is clear that cancers comprise a mixture of clones, a feature termed intra-clonal heterogeneity, ...
Multiple myeloma (MM) is a hematological malignancy resulting from the uncontrolled proliferation of...
Clonal heterogeneity and clonal evolution have emerged as critical concepts in the field of oncology...
Multiple Myeloma (MM) is a B-cell malignancy that is characterized by osteolytic bone lesions. It ha...
Although multiple myeloma (MM) is characterized by a monoclonal expansion of plasma cells, it has be...
Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone mar...